When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TAK - Biogen's Alzheimer's Drug And Other News: The Good Bad And Ugly Of Biopharma
Takeda Pharmaceutical Company Limited American Depositary Shares
Biogen receives priority review for Alzheimer’s drug candidate
Biogen (BIIB) announced that the FDA has accepted its Biologics License Application for aducanumab. The application has been granted Priority Review and its PDUFA date has been set at March 7, 2021. The agency has stated that it may take earlier action than the date. The company is collaborating with Eisai Co. Ltd. of Japan for developing this investigational treatment for Alzheimer’s disease.
Aducanumab has the potential to become the first treatment to bring significant change in the course of the disease for patients. The